Clinical phenotype in genetically confirmed von Willebrand disease type 2N patients reflects a haemophilia A phenotype

Haemophilia

Volumn 21, Issue 5, 2015, Pages e375-e383

  van Meegeren, M E R ^a   Mancini, T L ^a   Schoormans, S C M ^a   van Haren, B J T ^a   van Duren, C ^a   Diekstra, A ^a   Laros van Gorkom, B A P ^a   Brons, P P T ^a   Simons, A ^a   Hoefsloot, L ^a   van Heerde, W L ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Genotype; Haemorrhage; Phenotype; Von Willebrand disease type 2N; Von Willebrand factor

Indexed keywords

RISTOCETIN; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENOTYPE; HEMARTHROSIS; HEMOPHILIA A; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE HEMATOMA; PHENOTYPE; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; PROTEIN BINDING; RETROSPECTIVE STUDY; VON WILLEBRAND DISEASE; VON WILLEBRAND DISEASE TYPE 2N; ADOLESCENT; AGED; BLEEDING; CHILD; GENETICS; HETEROZYGOTE; MIDDLE AGED; MUTATION; PATHOLOGY; PRESCHOOL CHILD; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HEMOPHILIA A; HEMORRHAGE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; VON WILLEBRAND DISEASE, TYPE 2;

EID: 84942193431     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12733     Document Type: Article

References (28)

1. Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem 1998; 67: 395-424.
2. Zimmerman TS, Ruggeri ZM. von Willebrand disease. Hum Pathol 1987; 18: 140-52.
3. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 1987; 69: 454-9.
4. von Mazurier C. Willebrand disease masquerading as haemophilia A. Thromb Haemost 1992; 67: 391-6.
5. Costa-Pinto J, Pérez-Rodríguez A, Goméz-del-Castillo M, et al. Diagnosis of inherited von Willebrand disease: comparison of two methodologies and analysis of the discrepancies. Haemophilia 2014; 20: 559-67.
6. Mazurier C, Goudemand J, Hilbert L, Caron C, Fressinaud E, Meyer D. Type 2N von Willebrand disease: clinical manifestations, pathophysiology, laboratory diagnosis and molecular biology. Best Pract Res Clin Haematol 2001; 14: 337-47.
7. Lillicrap D. Genotype/phenotype association in von Willebrand disease: is the glass half full or empty? J Thromb Haemost 2009; 7(Suppl 1): 65-70.
8. Mazurier C, Dieval J, Jorieux S, Delobel J, Goudemand M. A new von Willebrand factor (vWF) defect in a patient with factor VIII (FVIII) deficiency but with normal levels and multimeric patterns of both plasma and platelet vWF. Characterization of abnormal vWF/FVIII interaction. Blood 1990; 75: 20-6.
9. http://www.vwf.group.shef.ac.uk.
10. http://www.ensembl.org.
11. Macfarlane DE, Stibbe J, Kirby EP, Zucker MB, Grant RA, McPherson J. Letter: a method for assaying von Willebrand factor (ristocetin cofactor). Thromb Diath Haemorrh 1975; 34: 306-8.
12. Caron C, Mazurier C, Goudemand J. Large experience with a factor VIII binding assay of plasma von Willebrand factor using commercial reagents. Br J Haematol 2002; 117: 716-8.
13. Taylor SL, Bromidge E, Savidge GF, Alhaq A. Evaluation of an automated screening assay for von Willebrand Disease Type 2N. Clin Lab Haematol 2002; 24: 369-75.
14. Rodgers SE, Lerda NV, Favaloro EJ, et al. Identification of von Willebrand disease type 2N (Normandy) in Australia: a cross-laboratory investigation using different methods. Am J Clin Pathol 2002; 118: 269-76.
15. Tosetto A, Rodeghiero F, Castaman G, et al. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost 2006; 4: 766-73.
16. de Wee EM, Sanders YV, Mauser-Bunschoten EP, et al. Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease. Thromb Haemost 2012; 108: 683-92.
17. Casonato A, Pontara E, Bertomoro A, Cattini M, Soldera C, Girolami A. Fainting induces an acute increase in the concentration of plasma factor VIII and von Willebrand factor. Haematologica 2003; 88(): 688-93.
18. Castaman G, Novella E, Contino L, Demicheli M, Rodeghiero F. First italian families with homozygous R854Q Type 2N von Willebrand disease. Thromb Haemost 2002; 88: 534-5.
19. Michiels JJ, Gadisseur A, Vangenegten I, Schroyens W, Berneman Z. Recessive von Willebrand disease type 2 normandy: variable expression of mild hemophilia and VWD type 1. Acta Haematol 2009; 121: 119-27.
20. Hilbert L, Jorieux S, Fontenay-Roupie M, et al. Expression of two type 2N von Willebrand disease mutations identified in exon 18 of von Willebrand factor gene. Br J Haematol 2004; 127: 184-9.
21. Hampshire DJ, Burghel GJ, Goudemand J, et al. Polymorphic variation within the VWF gene contributes to the failure to detect mutations in patients historically diagnosed with type 1 von Willebrand disease from the MCMDM-1VWD cohort. Haematologica 2010; 95: 2163-5.
22. Wang JW, Valentijn KM, de Boer HC, et al. Intracellular storage and regulated secretion of von Willebrand factor in quantitative von Willebrand disease. J Biol Chem 2011; 286: 24180-8.
23. Casonato A, Pontara E, Sartorello F, et al. Identifying carriers of type 2N von Willebrand disease: procedures and significance. Clin Appl Thromb Hemost 2007; 13: 194-200.
24. Veyradier A, Caron C, Ternisien C, et al. Validation of the first commercial ELISA for type 2N von Willebrand's disease diagnosis. Haemophilia 2011; 17: 944-51.
25. Tagliaferri A, Di Perna C, Riccardi F, Pattacini C, Rivolta GF, Franchini M. The natural history of mild haemophilia: a 30-year single centre experience. Haemophilia 2012; 18: 166-74.
26. Bowman M, Mundell G, Grabell J, et al. Generation and validation of the condensed MCMDM-1VWD bleeding questionnaire for von Willebrand disease. J Thromb Haemost 2008; 6: 2062-6.
27. Gill JC, Christopherson PA, Flood VH, Friedman KD, Montgomery RR. Bleeding Scores in von Willebrand Disease (VWD) re-visited: Analysis of the TS Zimmerman Program for the Molecular and Clinical Biology of VWD [abstract]. ASH Annual Meeting, San Francisco, CA. 2008.
28. Federici AB, Bucciarelli P, Castaman G, et al. The bleeding score predicts clinical outcomes and replacement therapy in adults with von Willebrand disease. Blood 2014; 123: 4037-44.